Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of FGF Receptors as an Emerging Therapeutic Target in Lung Squamous Cell Carcinoma

8 Mar 2013

Abstract excerpt

Recent advances in molecular medicine and high-throughput sequencing technologies have achieved major cancer strategies and therapeutics over the past decades. For example, identification of oncogenic EGF receptor mutations that are present in up to 20% of lung adenocarcinoma patients confer exquisite sensitivity to EGF receptor inhibitors. However, currently known 'druggable' targets are enriched in the subgroup...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fibroblast Growth Factor Research
Share to Kruppel-like factors research
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23469973
DOI: 10.2217/fon.12.190

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of FGF Receptors as an Emerging Therapeutic Target in Lung Squamous Cell CarcinomaPMID 23469973Read ↗

FGFR as potential target in the treatment of squamous non small cell lung cancer.Semantic proximity Read ↗

[Progress on the Study of Targeting FGFR in Squamous Non-small Cell Lung Cancer].Semantic proximity Read ↗

Inhibitor-sensitive FGFR2 and FGFR3 mutations in lung squamous cell carcinoma.Semantic proximity Read ↗

Targeting the Fibroblast Growth Factor Receptor (FGFR) Family in Lung Cancer.Semantic proximity Read ↗

Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung CancerSemantic proximity Read ↗

FGFR-driven lung cancer: Dissecting resistance and exploring therapeutic avenues.Semantic proximity Read ↗

Fibroblast Growth Factor Receptor 1-4 Genetic Aberrations as Clinically Relevant Biomarkers in Squamous Cell Lung CancerSemantic proximity Read ↗

Detection of Known and Novel FGFR Fusions in Non–Small Cell Lung Cancer by Comprehensive Genomic ProfilingSemantic proximity Read ↗

Genetic insight and therapeutic targets in squamous-cell lung cancer.Semantic proximity Read ↗

Fibroblast Growth Factor Receptor 1 and Related Ligands in Small-Cell Lung CancerSemantic proximity Read ↗

Mutational analysis of EGFR and related signaling pathway genes in lung adenocarcinomas identifies a novel somatic kinase domain mutation in FGFR4.Semantic proximity Read ↗

Fibroblast Growth Factor Receptors: From the Oncogenic Pathway to Targeted Therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.